Article 1 to 10 out of 22 for "Paclitaxel"
Ordered by
relevance
alphabet
date
GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes
(17 Jun 2008)
paclitaxel (TaxolŽ). The term...
Oncolytics Biotech Announces U.K. Phase II Clinical Trial Investigating REOLYSIN in Combination with Paclitaxel and Carboplatin
(16 May 2008)
paclitaxel ... I dose escalation trial of REOLYSIN(R) in combination with paclitaxel ...) given intravenously in combination with a standard dosage of paclitaxel ...
Antisoma announces start of phase III lung cancer trial of ASA404
(14 Apr 2008)
Initiation triggers USD 25 million milestone payment from Novartis
paclitaxel ) or a placebo plus chemotherapy (carboplatin/paclitaxel ) as a control. The primary endpoint...
UCB: Phase II results for CDP791 in non-small cell lung cancer support further clinical development
(01 Apr 2008)
paclitaxel chemotherapy in first line non-small cell lung cancer (NSCLC). Positive improvements...
Genentech Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel
(28 Aug 2007)
paclitaxel chemotherapy...
ABRAXANE demonstrates longer progression-free survival versus Taxotere in the treatment of first-line metastatic breast cancer
(05 Jun 2007)
paclitaxel protein-bound particles...) for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound (nab(TM)) paclitaxel ) received approval in June 2006 from...
MediGene Obtains European Patent on EndoTAG(TM)-1
(20 Feb 2007)
Paclitaxel ...
TopoTarget and CuraGen Initiate NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
(16 Nov 2006)
paclitaxel , cis-retinoic acid...
FDA Approves Avastin in Combination With Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer
(16 Oct 2006)
paclitaxel chemotherapy for the first-line treatment of patients... that patients receiving Avastin plus paclitaxel and carboplatin chemotherapy had..., compared to patients who received paclitaxel and carboplatin alone (based...
CuraGen and TopoTarget Initiate Clinical Program Evaluating Oral Administration of PXD101
(14 Aug 2006)
Phase I trial to establish the dose and frequency for oral PXD101 in patients with advanced solid tumors
paclitaxel for ovarian cancer, with cis...
Additional information matching your search term
Additional information was found matching your search for "Paclitaxel" .
Top